Compounds > praziquantel
Page last updated: 2024-11-03

praziquantel and Glomerulosclerosis, Focal Segmental

praziquantel has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

azinox: Russian drug

Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sobh, MA1
Moustafa, FE1
Sally, SM1
Deelder, AM1
Ghoniem, MA1

Other Studies

1 other study available for praziquantel and Glomerulosclerosis, Focal Segmental

ArticleYear
Effect of anti-schistosomal treatment on schistosomal-specific nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1988, Volume: 3, Issue:6

    Topics: Adult; Antibodies, Helminth; Antigens, Helminth; Female; Follow-Up Studies; Glomerulonephritis; Glom

1988